Disclosure of Industry Payments to Physicians An Epidemiologic Analysis of Early Data from the Open Payments Program

Mayo Clinic Proceedings

Volumn 91, Issue 1, 2016, Pages 84-96

  Marshall, Deborah C ^a,b   Jackson, Madeleine E ^b   Hattangadi Gluth, Jona A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; CHI SQUARE TEST; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; KRUSKAL WALLIS TEST; MEDICAL FEE; NEUROSURGEON; OSTEOPATHIC MEDICINE; PATHOLOGIST; PHYSICIAN; SURGERY; DRUG INDUSTRY; ECONOMICS; FACTUAL DATABASE; HEALTH CARE POLICY; INTERPERSONAL COMMUNICATION; MEDICARE; RETROSPECTIVE STUDY; SPECIALIZATION; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; UNITED STATES;

DATABASES, FACTUAL; DISCLOSURE; DRUG INDUSTRY; HOSPITALS, TEACHING; HUMANS; MEDICARE; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS; RETROSPECTIVE STUDIES; SPECIALIZATION; UNITED STATES;

EID: 84952802987     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.10.016     Document Type: Review

References (40)

1. Centers for Medicare and Medicaid Services Medicare, Medicaid, Children's Health Insurance Programs: transparency reports and reporting of physician ownership or investment interests: final rule Fed Regist 78 27 2013 9457 9528
2. E.G. Campbell, S.R. Rao, C.M. DesRoches, and et al. Physician professionalism and changes in physician-industry relationships from 2004 to 2009 Arch Intern Med 170 20 2010 1820 1826
3. B. Lo, and M.J. Field Conflict of Interest in Medical Research, Education, and Practice 2009 National Academies Press Washington, DC
4. A. Wazana Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283 3 2000 373 380
5. J. Dana, and G. Loewenstein A social science perspective on gifts to physicians from industry JAMA 290 2 2003 252 255
6. S. Chimonas, N.M. Rozario, and D.J. Rothman Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws Health Serv Res 45 1 2010 98 114
7. Department of Health and Human Services (DHHS), Office of the Inspector General OIG compliance program guidelines for pharmaceutical manufacturers Fed Regist 68 2003 23731
8. A.R. Hwong, N. Qaragholi, D. Carpenter, S. Joffe, E.G. Campbell, and L. Soleymani Lehmann A systematic review of state and manufacturer physician payment disclosure websites: implications for implementation of the Sunshine Act J Law Med Ethics 42 2 2014 208 219
9. A.S. Kesselheim, C.T. Robertson, K. Siri, P. Batra, and J.M. Franklin Distributions of industry payments to Massachusetts physicians N Engl J Med 368 22 2013 2049 2052
10. Drug Company Gift Disclosure Act of 2002, HR 5037, 107th Cong, 2nd Sess (2002).
11. Physician Payments Sunshine Act of 2007, S 2029, 110th Cong, 1st Sess (2007).
12. Physician Payments Sunshine Act of 2009, S 301, 111th Cong, 1st Sess (2009).
13. Patient Protection and Affordable Care Act, Public Law 111-148, USC HR 3590 (2010).
14. M.B. Rosenthal, and M.M. Mello Sunlight as disinfectant: new rules on disclosure of industry payments to physicians N Engl J Med 368 22 2013 2052 2054
15. S. Sah, and G. Loewenstein Nothing to declare: mandatory and voluntary disclosure leads advisors to avoid conflicts of interest Psychol Sci 25 2 2014 575 584
16. G. Pham-Kanter, G.C. Alexander, and K. Nair Effect of physician payment disclosure laws on prescribing Arch Intern Med 172 10 2012 819 821
17. Division of Survey and Data Resources, American Medical Association Physician Characteristics and Distribution in the United States 2013 American Medical Association Chicago, IL
18. Frequently asked questions (FAQ 8376). Centers for Medicare and Medicaid Services website. https://questions.cms.gov/faq.php?id=5005&faqId=8376. Accessed June 15, 2015.
19. Dollars for Docs: Open Payments explorer: how much industry money goes to doctors and teaching hospitals. ProPublica website. http://projects.propublica.org/open-payments. Accessed February 1, 2015.
20. D. Jarvies, R. Coombes, and W. Stahl-Timmins Open Payments goes live with pharma to doctor fee data: first analysis BMJ 349 2014 g6003
21. Department of Health and Human Services, Centers for Medicare and Medicaid Services Annual Report to Congress on the Open Payments Program for Fiscal Year 2014 2015 Centers for Medicare and Medicaid Services Baltimore, MD
22. Dollars for Docs: How industry dollars reach your doctors. ProPublica website. https://projects.propublica.org/docdollars. Accessed June 15, 2015.
23. E.G. Campbell, R.L. Gruen, J. Mountford, L.G. Miller, P.D. Cleary, and D. Blumenthal A national survey of physician-industry relationships N Engl J Med 356 17 2007 1742 1750
24. J.S. Chang The Physician Payments Sunshine Act: data evaluation regarding payments to ophthalmologists Ophthalmology 122 4 2015 656 661
25. V.K. Rathi, A.M. Samuel, and S. Mehra Industry ties in otolaryngology: initial insights from the physician payment sunshine act Otolaryngol Head Neck Surg 152 6 2015 993 999
26. A.M. Samuel, M.L. Webb, A.M. Lukasiewicz, and et al. Orthopaedic surgeons receive the most industry payments to physicians but large disparities are seen in Sunshine Act data Clin Orthop Relat Res 473 10 2015 3297 3306
27. A.K. Chatterji, K.R. Fabrizio, W. Mitchell, and K.A. Schulman Physician-industry cooperation in the medical device industry Health Aff (Millwood) 27 6 2008 1532 1543
28. J.D. Zuckerman, M. Prasarn, E.N. Kubiak, and K.J. Koval Conflict of interest in orthopaedic research J Bone Joint Surg Am 86 2 2004 423 428
29. R.H. Gelberman, D. Samson, S.K. Mirza, J.J. Callaghan, and V.D. Pellegrini Jr. Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust J Bone Joint Surg Am 92 3 2010 765 777
30. T.K. Mackey, and B.A. Liang Physician payment disclosure under health care reform: will the sun shine? J Am Board Fam Med 26 3 2013 327 331
31. G. Loewenstein, S. Sah, and D.M. Cain The unintended consequences of conflict of interest disclosure JAMA 307 7 2012 669 670
32. B. Moy, R. Jagsi, R.B. Gaynor, and M.J. Ratain The impact of industry on oncology research and practice Am Soc Clin Oncol Educ Book 35 2015 130 137
33. N.M. Kirschner, L.S. Sulmasy, and A.S. Kesselheim Health policy basics: the Physician Payment Sunshine Act and the Open Payments program Ann Intern Med 161 7 2014 519 521
34. S.R. Morain, C. Flexner, N.E. Kass, and J. Sugarman Forecast for the Physician Payment Sunshine Act: partly to mostly cloudy? Ann Intern Med 161 12 2014 915 916
35. S. Santhakumar, and E.Y. Adashi The Physician Payment Sunshine Act: testing the value of transparency JAMA 313 1 2015 23 24
36. E.C. Richardson, A, R. Saver, R. Lott, and T. Gnadinger Health Policy Brief: The Physician Payments Sunshine Act," Health Affairs October 2, 2014
37. L.A. Hampson, M. Agrawal, S. Joffe, C.P. Gross, J. Verter, and E.J. Emanuel Patients' views on financial conflicts of interest in cancer research trials N Engl J Med 355 22 2006 2330 2337
38. M.H. Khan, J.Y. Lee, J.A. Rihn, and et al. The surgeon as a consultant for medical device manufacturers: what do our patients think? Spine (Phila Pa 1976) 32 23 2007 2616 2618 discussion 2619
39. H. Moses III, D.H. Matheson, S. Cairns-Smith, B.P. George, C. Palisch, and E.R. Dorsey The anatomy of medical research: US and international comparisons JAMA 313 2 2015 174 189
40. M.J. Ratain Forecasting unanticipated consequences of "The Sunshine Act": mostly cloudy J Clin Oncol 32 22 2014 2293 2295